Medication info
Expol Tablet 5/160mg (Amlodipine, Valsartan)

Expol Tablet 5/160mg (Amlodipine, Valsartan)

Prescription medicationTabletOral
Ingredient · strength
Valsartan›160mg / 1 tabletAmlodipine Besylate›6.94mg / 1 tablet
Manufacturer / importer
Seongwon Adcock Pharmaceutical Co., Ltd.
Appearance
Dark yellow rectangular film-coated tablets
Packaging
28 tablets (14 tablets/Alu-Alu packaging * 2)
Approval status
Active

MFDS item code 201309499 · Approved 2013.09.30 · Insurance code 664900970

Summary

Main use
Treatment of essential hypertension not controlled by monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose of this medicine is 1 tablet once daily, taken with water regardless of meals. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). It is recommended that the dose be adjusted using the individual components (amlodipine or valsartan) before administering this medicine; however, direct conversion to this medicine may be considered if blood pressure is not adequately controlled with monotherapy using the individual components, as follows: ㆍ5/80 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 80 milligrams as monotherapy. ㆍ5/160 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 160 milligrams as monotherapy. ㆍ10/160 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams or valsartan 160 milligrams as monotherapy, or with 5/160 milligrams. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or greater), but this medicine should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or those on dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. Do not administer this medicine to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Older patients aged 65 years or older: Use caution when increasing the dose.
Child dose
Use of this medicine is not recommended in pediatric patients under 18 years of age because its safety and efficacy have not been established.

Ingredients

Manufacturer
Seongwon Adcock Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled by monotherapy

  • Essential hypertension
View approved original text

This medication is used to help lower blood pressure more effectively when essential hypertension is not adequately controlled with Amlodipine or Valsartan monotherapy. This helps reduce the burden on the heart and kidneys and contributes to the prevention of complications. It is used to improve the management of your blood pressure and maintain a healthy life.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet once daily, taken with water regardless of meals. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). It is recommended that the dose be adjusted using the individual components (amlodipine or valsartan) before administering this medicine; however, direct conversion to this medicine may be considered if blood pressure is not adequately controlled with monotherapy using the individual components, as follows: ㆍ5/80 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 80 milligrams as monotherapy. ㆍ5/160 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 160 milligrams as monotherapy. ㆍ10/160 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams or valsartan 160 milligrams as monotherapy, or with 5/160 milligrams. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or greater), but this medicine should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or those on dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. Do not administer this medicine to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Older patients aged 65 years or older: Use caution when increasing the dose.

Child dose

Use of this medicine is not recommended in pediatric patients under 18 years of age because its safety and efficacy have not been established.

Precautions

This medication can cause serious harm to the fetus and newborn when used during the second and third trimesters of pregnancy, so it should be discontinued immediately upon confirmation of pregnancy. Patients who are allergic to any of the active ingredients or similar components, pregnant or breastfeeding women, patients with severe kidney or liver impairment, and those with certain heart conditions should not take this medication. Patients with low sodium or fluid levels in the body may experience hypotension, so it's essential to check their condition before taking this medication and to monitor their blood pressure and condition closely during treatment. Patients with high potassium levels or poor kidney function should frequently check their potassium levels while using this medication, and medication adjustments may be necessary if required. When administering this medication to patients after heart failure or myocardial infarction, kidney function and blood pressure changes must be monitored closely, and it should be used cautiously in patients with severe heart failure. Symptoms such as dizziness, headache, swelling, hypotension, etc., may occur while taking this medication, so if unusual symptoms appear, consult a physician. Caution is needed when driving or operating machinery, as dizziness or fatigue may occur. There may be interactions when taken with other medications, so if you are taking any current medications, be sure to inform your physician or pharmacist. Women who are pregnant or planning to become pregnant should not use this medication, and it is also advisable to avoid it while breastfeeding. Safety and effectiveness in children under 18 years of age have not been sufficiently established, so its use is not recommended. In case of overdose, hypotension, dizziness, arrhythmias, etc., may occur, and you should visit a medical facility immediately for appropriate treatment if necessary.

Side effects

nasopharyngitis, influenza, hypersensitivity, visual impairment, anxiety, headache, dizziness, drowsiness, orthostatic dizziness, sensory disturbance, vertigo, tinnitus, tachycardia, palpitations, syncope, orthostatic hypotension, hypotension, cough, pharyngeal and laryngeal pain, diarrhea, nausea, abdominal pain, constipation, dry mouth, rash, erythema, hyperhidrosis, itching, joint swelling, low back pain, arthritis, muscle cramps, weakness, polyuria, nocturia, erectile dysfunction, edema, angioneurotic edema, facial edema, peripheral edema, fatigue, flushing, asthenia, facial flushing, hemoglobin decrease, hematocrit decrease, neutropenia, thrombocytopenia, hypersensitivity including serum sickness, hyperkalemia, vasculitis, elevated liver function tests, angioedema, myalgia, renal failure, kidney damage, elevated serum creatinine, insomnia, decreased libido, pharyngitis, rhinitis, sinusitis, upper respiratory infection, viral infection, diplopia, thrombocytopenia, leukopenia, allergic reaction, hyperglycemia, insomnia, mood changes, tremor, sensory loss, taste disturbance, peripheral neuropathy, excessive muscle tension, arrhythmia, bradycardia, atrial fibrillation, ventricular tachycardia, myocardial infarction, vasculitis, dyspnea, rhinitis, vomiting, dyspepsia, pancreatitis, gastritis, gingival hyperplasia, hepatitis, jaundice, alopecia, purpura, skin depigmentation, photosensitivity reaction, angioedema, urticaria, erythema multiforme, Stevens-Johnson syndrome, myalgia, voiding disorders, nocturnal enuresis, gynecomastia, pain, malaise, chest pain, weight loss, weight gain, elevated liver enzymes, chest discomfort, abdominal discomfort, gastroesophageal reflux, neck pain, hypercholesterolemia, hypoglycemia, neuroirritability, sensory loss, Stevens-Johnson syndrome, chest pain, weight gain, arthralgia, skeletal pain, rhabdomyolysis, gingival hyperplasia, gastritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent exposure to air and moisture. It is important to maintain storage temperature between 1 and 30 degrees Celsius.

Appearance and packaging

Appearance

Dark yellow rectangular film-coated tablets

Package unit

28 tablets (14 tablets/Alu-Alu packaging * 2)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.